Literature DB >> 18097047

B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms.

Javier Rangel-Moreno1, Damian M Carragher, Ravi S Misra, Kim Kusser, Louise Hartson, Amy Moquin, Frances E Lund, Troy D Randall.   

Abstract

Immunity to heterosubtypic strains of influenza is thought to be mediated primarily by memory T cells, which recognize epitopes in conserved proteins. However, the involvement of B cells in this process is controversial. We show in this study that influenza-specific memory T cells are insufficient to protect mice against a lethal challenge with a virulent strain of influenza in the absence of B cells. B cells contribute to protection in multiple ways. First, although non-neutralizing Abs by themselves do not provide any protection to challenge infection, they do reduce weight loss, lower viral titers, and promote recovery of mice challenged with a virulent heterosubtypic virus in the presence of memory T cells. Non-neutralizing Abs also facilitate the expansion of responding memory CD8 T cells. Furthermore, in cooperation with memory T cells, naive B cells also promote recovery from infection with a virulent heterosubtypic virus by generating new neutralizing Abs. These data demonstrate that B cells use multiple mechanisms to promote resistance to heterosubtypic strains of influenza and suggest that vaccines that elicit both memory T cells and Abs to conserved epitopes of influenza may be an effective defense against a wide range of influenza serotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097047      PMCID: PMC2712821          DOI: 10.4049/jimmunol.180.1.454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  T cell memory in the lung airways.

Authors:  David L Woodland; Iain Scott
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.

Authors:  Sherry R Crowe; Shannon C Miller; Rachael M Shenyo; David L Woodland
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

3.  Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes.

Authors:  S Sambhara; S Woods; R Arpino; A Kurichh; A Tamane; B Underdown; M Klein; K Lövgren Bengtsson; B Morein; D Burt
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

4.  A universal influenza A vaccine based on the extracellular domain of the M2 protein.

Authors:  S Neirynck; T Deroo; X Saelens; P Vanlandschoot; W M Jou; W Fiers
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

Review 5.  Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Authors:  P C Doherty; D J Topham; R A Tripp; R D Cardin; J W Brooks; P G Stevenson
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

6.  Modified M2 proteins produce heterotypic immunity against influenza A virus.

Authors:  A M Frace; A I Klimov; T Rowe; R A Black; J M Katz
Journal:  Vaccine       Date:  1999-05-04       Impact factor: 3.641

7.  TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.

Authors:  D Marshall; R Sealy; M Sangster; C Coleclough
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

8.  CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection.

Authors:  Byung O Lee; Javier Rangel-Moreno; Juan E Moyron-Quiroz; Louise Hartson; Melissa Makris; Frank Sprague; Frances E Lund; Troy D Randall
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

9.  Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.

Authors:  K Mozdzanowska; K Maiese; M Furchner; W Gerhard
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

10.  Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.

Authors:  H H Nguyen; Z Moldoveanu; M J Novak; F W van Ginkel; E Ban; H Kiyono; J R McGhee; J Mestecky
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

View more
  48 in total

Review 1.  Protective B cell responses to flu--no fluke!

Authors:  Elizabeth E Waffarn; Nicole Baumgarth
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

2.  Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus.

Authors:  Jae-Min Song; Nico Van Rooijen; Jadranka Bozja; Richard W Compans; Sang-Moo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.

Authors:  Alina C Boesteanu; Nadarajan S Babu; Margaret Wheatley; Elisabeth S Papazoglou; Peter D Katsikis
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

4.  Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.

Authors:  Maria E Lorenzo; Andrea Hodgson; Dionne P Robinson; Jenifer B Kaplan; Andrew Pekosz; Sabra L Klein
Journal:  Vaccine       Date:  2011-10-06       Impact factor: 3.641

5.  Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.

Authors:  John R Teijaro; David Verhoeven; Carly A Page; Damian Turner; Donna L Farber
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.

Authors:  Yo Han Jang; Young Ho Byun; Yoon Jae Lee; Yun Ha Lee; Kwang-Hee Lee; Baik Lin Seong
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

7.  Long-Lasting Impact of Neonatal Exposure to Total Body Gamma Radiation on Secondary Lymphoid Organ Structure and Function.

Authors:  Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Rosalio Ramos-Payan; Jamie Biear; Eric Hernady; Mark Y Sangster; Troy D Randall; Carl J Johnston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2015-09-23       Impact factor: 2.841

8.  Rituximab-treated patients have a poor response to influenza vaccination.

Authors:  Robert A Eisenberg; Abbas F Jawad; Jean Boyer; Kelly Maurer; Kenyetta McDonald; Eline T Luning Prak; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

9.  Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach.

Authors:  Rong Hai; Luis Martínez-Sobrido; Kathryn A Fraser; Juan Ayllon; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

10.  A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

Authors:  Damian M Carragher; Denise A Kaminski; Amy Moquin; Louise Hartson; Troy D Randall
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.